Skip to main content

Table 1 Baseline characteristics of 225 couples from the EARTH study in relation to female smoking status

From: Discrete survival model analysis of a couple’s smoking pattern and outcomes of assisted reproduction

  Female Smoking Status P-value a
Never smoker Former smoker Current smoker
Number of couples, n (%) 167 (74.2) 51 (22.7) 7 (3.1) <0.001
Total ART cycles, n (%) 249 (70.3) 93 (26.3) 12 (3.4) <0.001
Female Characteristics b
 Age, years 35 (32, 38) 34 (33, 37) 34 (29, 37) 0.89
 Body Mass Index, kg/m2 22.6 (20.4, 26.3) 22.7 (21.5, 24.7) 25.7 (23.8, 28.2) 0.11
 At least college education, n (%) 148 (88.6) 39 (76.5) 5 (71.4) 0.04
 Non-Hispanic Caucasian, n (%) 143 (85.6) 43 (84.3) 7 (100) 0.74
 Pack-years NA 1.6 (0.5, 4.6) 2.4 (1.0, 4.2) 0.65
 Total smoking duration, years NA 9 (5, 13) 14 (8, 16) 0.08
 Average cigarettes smoked NA 4.0 (1.5, 10.0) 5.0 (1.5, 7.0) 0.89
 Age of smoking initiation, years NA 17 (15, 18) 18 (18, 20) 0.04
 Total Smoking cessation, years NA 8.0 (5.0, 12.0) 0.2 (0.2, 0.2) <0.001
 Exposed to passive smoking, n (%) 30 (18.0) 14 (27.5) 2 (28.6) 0.23
Male Partner Characteristics
 Partner age, years 36 (33, 40) 35 (33, 40) 39 (35, 41) 0.40
 Partner body mass index, kg/m2 26.9 (24.2, 29.3) 26.9 (24.5, 29.3) 27.9 (25.1, 28.3) 0.97
 Partner former smoker, n (%) 38 (22.8) 16 (31.4) 1 (14.3) 0.44
 Partner current smoker, n (%) 8 (4.8) 4 (7.8) 4 (57.1) <0.001
Baseline Reproductive Characteristics
 Previous IUI, n (%) 71 (42.5) 19 (37.3) 2 (28.6) 0.70
 Previous IVF, n (%) 40 (24.0) 8 (15.7) 1 (14.3) 0.51
 ICSI, n (%) 83 (49.7) 31 (60.8) 4 (57.1) 0.37
 Infertility diagnosis, n (%)     0.47
  Male factor 55 (32.9) 20 (39.2) 4 (57.1)  
  Diminished ovarian reserve 9 (5.9) 3 (5.9) 1 (14.3)  
  Endometriosis 10 (6.0) 3 (5.9) 0 (0.0)  
  Ovulatory dysfunction 15 (9.0) 5 (9.8) 0 (0.0)  
  Tubal causes 11 (6.6) 8 (15.7) 1 (14.3)  
  Uterine causes 3 (1.8) 0 (0.0) 0 (0.0)  
  Unexplained 64 (38.3) 12 (23.5) 1 (14.3)  
 Initial treatment protocol, n (%)     0.69
  Antagonist 21 (12.6) 5 (9.8) 1 (14.3)  
  Flare 17 (10.2) 8 (15.7) 0 (0.0)  
  Luteal phase agonist 129 (77.3) 38 (75.5) 6 (85.7)  
 Day 3 FSH levels, IU/L 6.6 (5.8, 8.0) 7.3 (6.0, 8.8) 8.1 (7.0, 8.3) 0.16
 E2 Trigger levels, pmol/L 2126 (1632, 2639) 1828 (1459, 2532) 1798 (1540, 1953) 0.17
 Day of embryo transfer, n (%)     0.01
  No transfer 11 (6.6) 4 (7.8) 2 (28.6)  
  Day 2 4 (2.4) 5 (2.2) 0 (0.0)  
  Day 3 79 (47.6) 29 (56.9) 1 (14.3)  
  Day 5 72 (43.4) 13 (25.5) 4 (57.1)  
 Number of embryos transferred, n (%)     <0.001
  No transfers 11 (6.6) 4 (7.8) 2 (28.6)  
  1 embryo 42 (25.3) 2 (3.9) 2 (28.6)  
  2 embryos 81 (48.8) 41 (80.4) 3 (42.7)  
  3 or more embryos 32 (19.3) 4 (7.8) 0 (0.0)  
  1. aFrom Chi-square or Fisher test for discrete variables and Kruskal-Wallis for continuous variables
  2. bContinuous variables are presented as median (25th percentile, 75th percentile) while categorical variables are presented as number of women (percent)
  3. Abbreviations: ART Assisted reproductive technology, BMI Body mass index, E2 estradiol, FSH follicle stimulating hormone, IVF In-vitro fertilization, ICSI Intracytoplasmic sperm injection, IUI intrauterine sperm insemination